Status:
NOT_YET_RECRUITING
Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
Samsung Medical Center, Sungkyunkwan University School of Medicine
Conditions:
Gastric Adenoma
Stomach Neoplasms
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Gastric adenomas with low-grade dysplasia (LGD) are considered precancerous lesions of the stomach. While these lesions carry a lower risk of progressing to gastric cancer compared with high-grade dys...
Detailed Description
Gastric adenomas with low-grade dysplasia (LGD) represent precancerous changes in the stomach lining. Unlike high-grade dysplasia (HGD), which carries a well-established high risk of progression to ga...
Eligibility Criteria
Inclusion
- Adults aged 20 years or older
- Diagnosed with gastric adenoma with low-grade dysplasia measuring ≤ 1 cm on endoscopy
- Scheduled to undergo endoscopic treatment
- Able and willing to provide written informed consent
Exclusion
- Previous treatment for gastric adenoma or gastric cancer
- History of gastrectomy
- Diagnosis of gastric cancer or high-grade dysplasia at the time of enrollment
- Presence of multiple gastric adenomas
- Pregnant, breastfeeding, or possibility of pregnancy
- Uncontrolled chronic illnesses that may interfere with trial participation (e.g., uncontrolled hypertension, uncontrolled diabetes, chronic kidney disease, ascites, heart failure, psychiatric disorders)
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT07161479
Start Date
September 1 2025
End Date
October 1 2026
Last Update
September 12 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center
Goyang-si, South Korea, 10408
2
Kangbuk Samsung hospital
Seoul, South Korea, 03181
3
Samsung Medical Center
Seoul, South Korea, 06351